Reis F M, Ribeiro M F, Spritzer P M
Gynecological Endocrinology Unit, Hospital de Clínicas, and Department of Physiology, UFRGS, Porto Alegre, Brazil.
Gynecol Obstet Invest. 1999;47(2):120-4. doi: 10.1159/000010074.
The objective of the present study was to evaluate the cyclic changes and regional localization of immunoreactive c-fos and prolactin (PRL) in the human endometrium, using immunohistochemistry. Immunoreactive PRL was found in the epithelium of 9.1% of the proliferative specimens and in 55.6% of the secretory specimens (p < 0.05, Fisher's exact test). In the endometrial stroma, immunoreactive PRL was present in 9.1 and 66.7% of the proliferative and secretory samples, respectively (p < 0.01). Immunoreactive c-fos predominated in the stroma and was identified in 54.5% of the specimens in the proliferative phase, but in only 7.1% of those in the secretory phase (p < 0.05). The progesterone/estradiol ratio was lower in the patients expressing immunoreactive c-fos (median = 13.1 ng/ml) compared to those who did not (median = 84.5 ng/ml, p < 0.05). We conclude that immunoreactive c-fos is found mostly in stromal cells during the proliferative phase of the menstrual cycle, and is sharply reduced during the secretory phase, when the endometrium is under progesterone stimulation - attested by PRL production.
本研究的目的是利用免疫组织化学方法评估人子宫内膜中免疫反应性c-fos和催乳素(PRL)的周期性变化及区域定位。在9.1%的增殖期标本上皮细胞和55.6%的分泌期标本上皮细胞中发现免疫反应性PRL(p<0.05,Fisher精确检验)。在子宫内膜基质中,免疫反应性PRL分别存在于9.1%的增殖期样本和66.7%的分泌期样本中(p<0.01)。免疫反应性c-fos在基质中占主导,在增殖期54.5%的标本中可检测到,但在分泌期标本中仅7.1%可检测到(p<0.05)。与未表达免疫反应性c-fos的患者相比,表达免疫反应性c-fos的患者孕酮/雌二醇比值较低(中位数=13.1 ng/ml)(中位数=84.5 ng/ml,p<0.05)。我们得出结论,免疫反应性c-fos在月经周期的增殖期主要存在于基质细胞中,而在分泌期,当子宫内膜受到孕酮刺激(通过PRL产生证明)时,其含量急剧下降。